FI760344A7 - - Google Patents

Info

Publication number
FI760344A7
FI760344A7 FI760344A FI760344A FI760344A7 FI 760344 A7 FI760344 A7 FI 760344A7 FI 760344 A FI760344 A FI 760344A FI 760344 A FI760344 A FI 760344A FI 760344 A7 FI760344 A7 FI 760344A7
Authority
FI
Finland
Application number
FI760344A
Other languages
Finnish (fi)
Other versions
FI67415B (fi
FI67415C (fi
Inventor
Howard B Lange
Original Assignee
Babcock & Wilcox Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babcock & Wilcox Co filed Critical Babcock & Wilcox Co
Publication of FI760344A7 publication Critical patent/FI760344A7/fi
Publication of FI67415B publication Critical patent/FI67415B/fi
Application granted granted Critical
Publication of FI67415C publication Critical patent/FI67415C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
FI760344A 1975-02-21 1976-02-12 Foerfarande foer behandling av sulfatavlut FI67415C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55181175 1975-02-21
US05/551,811 US3934013A (en) 1975-02-21 1975-02-21 Pharmaceutical composition

Publications (3)

Publication Number Publication Date
FI760344A7 true FI760344A7 (enExample) 1976-08-22
FI67415B FI67415B (fi) 1984-11-30
FI67415C FI67415C (fi) 1985-03-11

Family

ID=24202770

Family Applications (1)

Application Number Title Priority Date Filing Date
FI760344A FI67415C (fi) 1975-02-21 1976-02-12 Foerfarande foer behandling av sulfatavlut

Country Status (18)

Country Link
US (1) US3934013A (enExample)
JP (1) JPS6135166B2 (enExample)
AU (1) AU504748B2 (enExample)
BE (1) BE838711A (enExample)
BR (1) BR7600834A (enExample)
CA (1) CA1067409A (enExample)
DE (1) DE2605242A1 (enExample)
DK (1) DK68876A (enExample)
ES (1) ES445151A1 (enExample)
FI (1) FI67415C (enExample)
FR (1) FR2301262A1 (enExample)
GB (1) GB1502544A (enExample)
IE (1) IE43655B1 (enExample)
IL (1) IL48797A (enExample)
IT (1) IT1066085B (enExample)
NL (1) NL7601667A (enExample)
NZ (1) NZ180042A (enExample)
ZA (1) ZA7671B (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
IL53617A0 (en) * 1976-12-17 1978-03-10 Scherico Ltd Improvements in or relating to antibiotic formulations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4780455A (en) * 1985-04-12 1988-10-25 The Trustees Of Columbia University In The City Of New York Lipophilic complexes of pharmacologically active organic compounds
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4792556A (en) 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
UA39896C2 (uk) * 1993-10-22 2001-07-16 Смітклайн Бічам Корпорейшн Фармацевтична або ветеринарна композиція мупіроцину та спосіб її приготування
AU7510394A (en) * 1994-07-15 1996-02-16 Cohen, Michel Synergistic pharmaceutical compositons containing 16alpha,17alpha-isopropylidenedioxy substituted pregnanes
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
RU2106860C1 (ru) * 1996-01-30 1998-03-20 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав и способ получения мази противовоспалительного и противозудного действия
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
WO2000051980A1 (en) 1999-03-05 2000-09-08 The Procter & Gamble Company C16 unsaturated fp-selective prostaglandins analogs
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
EP2366408B1 (en) * 2010-03-01 2012-07-18 Laboratorios SALVAT, S.A. Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
JP6487949B2 (ja) 2014-03-11 2019-03-20 プロミウス ファーマ, エルエルシーPromius Pharma, Llc 局所用コルチコステロイド組成物
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy
WO2019014299A1 (en) * 2017-07-11 2019-01-17 University Of Miami TOPICAL FORMULATIONS OF ACETAMINOPHENE FOR RELIEF RELIEF
EP4188333A1 (en) 2020-07-28 2023-06-07 Arcutis Biotherapeutics, Inc. Topical formulation containing jak inhibitor and laureth-4
EP4447930A1 (en) 2021-12-15 2024-10-23 Arcutis Biotherapeutics, Inc. Stable formulations of shr0302

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073743A (en) * 1959-07-30 1963-01-15 Upjohn Co Antiinflammatory steroid acetonide compositions and therapy
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides

Also Published As

Publication number Publication date
IE43655B1 (en) 1981-04-22
DE2605242A1 (de) 1976-09-02
ES445151A1 (es) 1977-05-16
IL48797A0 (en) 1976-03-31
AU1085876A (en) 1977-03-17
AU1068276A (en) 1977-08-04
ZA7671B (en) 1977-08-31
NZ180042A (en) 1978-07-28
BE838711A (fr) 1976-08-19
FR2301262A1 (fr) 1976-09-17
AU504748B2 (en) 1979-10-25
FI67415B (fi) 1984-11-30
IT1066085B (it) 1985-03-04
NL7601667A (nl) 1976-08-24
FR2301262B1 (enExample) 1979-04-06
JPS6135166B2 (enExample) 1986-08-12
CA1067409A (en) 1979-12-04
BR7600834A (pt) 1976-09-14
JPS51110043A (enExample) 1976-09-29
FI67415C (fi) 1985-03-11
US3934013A (en) 1976-01-20
IE43655L (en) 1976-08-21
IL48797A (en) 1979-01-31
GB1502544A (en) 1978-03-01
DK68876A (da) 1976-08-22

Similar Documents

Publication Publication Date Title
JPS51120695U (enExample)
CH596630A5 (enExample)
BG22165A1 (enExample)
BG22187A1 (enExample)
BG22312A1 (enExample)
BG22431A1 (enExample)
BG22546A1 (enExample)
BG22629A1 (enExample)
BG22630A1 (enExample)
BG22704A2 (enExample)
BG22722A1 (enExample)
BG23278A1 (enExample)
BG26243A1 (enExample)
CH1386575A4 (enExample)
CH1426175A4 (enExample)
CH584087A5 (enExample)
CH584477A5 (enExample)
CH585089A5 (enExample)
CH585833A5 (enExample)
CH589366A5 (enExample)
CH590401A5 (enExample)
CH591043A5 (enExample)
CH591239A5 (enExample)
CH591774A5 (enExample)
CH591799A5 (enExample)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: THE BABCOCK & WILCOX CO.